Neo Ivy Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,790
| Closed | -$268K | – | 472 |
|
|
2025
Q1 | $268K | Buy |
+6,790
| New | +$268K | 0.09% | 216 |
|
|
2024
Q4 | – | Sell |
-100,780
| Closed | -$2.36M | – | 400 |
|
|
2024
Q3 | $2.36M | Buy |
+100,780
| New | +$2.36M | 0.76% | 44 |
|
|
2023
Q3 | – | Sell |
-15,099
| Closed | -$375K | – | 452 |
|
|
2023
Q2 | $375K | Buy |
+15,099
| New | +$375K | 0.2% | 147 |
|
|
2021
Q4 | – | Sell |
-5,209
| Closed | -$101K | – | 625 |
|
|
2021
Q3 | $101K | Sell |
5,209
-2,495
| -32% | -$48.4K | 0.12% | 245 |
|
|
2021
Q2 | $299K | Buy |
7,704
+5,635
| +272% | +$219K | 0.3% | 127 |
|
|
2021
Q1 | $100K | Sell |
2,069
-418
| -17% | -$20.2K | 0.11% | 244 |
|
|
2020
Q4 | $129K | Sell |
2,487
-2,721
| -52% | -$141K | 0.14% | 220 |
|
|
2020
Q3 | $139K | Sell |
5,208
-1
| -0% | -$27 | 0.14% | 240 |
|
|
2020
Q2 | $101K | Buy |
+5,209
| New | +$101K | 0.12% | 245 |
|